- Home
- VTRS vs CMA Comparison
VTRS vs CMA Comparison
Compare VTRS & CMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTRS
- CMA
- Stock Information
- Founded
- VTRS 1961
- CMA 1849
- Country
- VTRS United States
- CMA United States
- Employees
- VTRS N/A
- CMA N/A
- Industry
- VTRS Medicinal Chemicals and Botanical Products
- CMA Major Banks
- Sector
- VTRS Health Care
- CMA Finance
- Exchange
- VTRS Nasdaq
- CMA Nasdaq
- Market Cap
- VTRS 11.1B
- CMA 9.6B
- IPO Year
- VTRS N/A
- CMA N/A
- Fundamental
- Price
- VTRS $10.37
- CMA $78.39
- Analyst Decision
- VTRS Hold
- CMA Hold
- Analyst Count
- VTRS 6
- CMA 22
- Target Price
- VTRS $11.17
- CMA $71.86
- AVG Volume (30 Days)
- VTRS 7.1M
- CMA 4.1M
- Earning Date
- VTRS 11-06-2025
- CMA 10-17-2025
- Dividend Yield
- VTRS 4.64%
- CMA 3.63%
- EPS Growth
- VTRS N/A
- CMA 30.51
- EPS
- VTRS N/A
- CMA 5.23
- Revenue
- VTRS $14,115,700,000.00
- CMA $3,234,000,000.00
- Revenue This Year
- VTRS N/A
- CMA $6.48
- Revenue Next Year
- VTRS $1.61
- CMA $3.12
- P/E Ratio
- VTRS N/A
- CMA $14.96
- Revenue Growth
- VTRS N/A
- CMA 2.31
- 52 Week Low
- VTRS $6.85
- CMA $48.12
- 52 Week High
- VTRS $13.55
- CMA $83.22
- Technical
- Relative Strength Index (RSI)
- VTRS 61.57
- CMA 60.43
- Support Level
- VTRS $10.30
- CMA $76.46
- Resistance Level
- VTRS $10.52
- CMA $78.17
- Average True Range (ATR)
- VTRS 0.21
- CMA 2.31
- MACD
- VTRS 0.05
- CMA -0.14
- Stochastic Oscillator
- VTRS 81.82
- CMA 58.45
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
About CMA Comerica Incorporated
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.